PlainRecalls
FDA Drug Low Class III Terminated

Carvedilol Tablets, USP, 3.125 mg, 500-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; NDC 68382-092-05

Reported: May 1, 2019 Initiated: April 22, 2019 #D-1242-2019

Product Description

Carvedilol Tablets, USP, 3.125 mg, 500-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; NDC 68382-092-05

Reason for Recall

Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg.

Details

Units Affected
7668 bottles
Distribution
Nationwide in the USA
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
Carvedilol Tablets, USP, 3.125 mg, 500-count bottle, Rx Only, Manufactured by: Cadila Healthcare Ltd., India; Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534; NDC 68382-092-05. Recalled by Zydus Pharmaceuticals USA Inc. Units affected: 7668 bottles.
Why was this product recalled?
Presence of Foreign Tablets/Capsules: Customer complaint for a small, solid, light yellow substance, identified as a fragmented tablet of another drug product, found mixed with tablets in a bottle of Carvedilol tablets 3.125mg.
Which agency issued this recall?
This recall was issued by the FDA Drug on May 1, 2019. Severity: Low. Recall number: D-1242-2019.